Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis
Bacterial Vaginosis, HUDC_VT, Haudongchun
About this trial
This is an interventional treatment trial for Bacterial Vaginosis
Eligibility Criteria
Inclusion Criteria:
- Fertile women
Clinical diagnosis of bacterial vaginosis with criteria on below (3 out of 4 fulfilled criteria)
- light gray adherent vaginal discharge
- pH >4.5
- Presence of clue cells ≥20%
- Positive "10% KOH whiff test"
- Nugent Score ≥ 4
Exclusion Criteria:
- Pregnant or breast-feeding patient or planning pregnancy
- Patient with candidiasis, Chlamydia trachomatis, Trichomonas vaginalis, Neisseria gonorrhoeae or Herpes simplex virus infection
- Patient who received antifungal or antimicrobial therapy (systemic or intravaginal) within 30 days of randomization
- Any condition or circumstance that would interfere with analysis of study results
- Patient who have a plan to treat other disease (e.g cervical carcinoma) during clinical study period
Sites / Locations
- Korea University Guro HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Experimental
Experimental
Placebo Comparator
HUDC_VT(Glucose 200mg/Sodium chloride 200mg)
HUDC_VT(Glucose 400mg/Sodium chloride 200mg)
HUDC_VT(Glucose 400mg)
HUDC_VT(Sodium chloride 200mg)
Placebo
Glucose 200mg/Sodium chloride 200mg, once a day, two tablets at a time for 7 days
Glucose 400mg/Sodium chloride 200mg, once a day, two tablets at a time for 7 days
Glucose 400mg, once a day, two tablets at a time for 7 days
Sodium chloride 200mg, once a day, two tablets at a time for 7 days
Placebo, once a day, two tablets at a time for 7 days